Followers | 4053 |
Posts | 151254 |
Boards Moderated | 4 |
Alias Born | 08/05/2009 |
Thursday, April 20, 2023 9:18:41 AM
The Purchase Agreement contains representations and warranties of the Company and the Purchasers that are typical for transactions of this type. The Purchase Agreement also contains covenants on the part of the Company that are typical for transactions of this type.
The Purchase Agreement also contemplates that Redmile and the Company will finalize and enter into a separate equity line of credit within 30 days of the date of the Purchase Agreement, subject to the approval of the Company’s stockholders. This equity line of credit would allow the Company to sell shares of Common Stock having an aggregate price of up to $5,000,000 to Redmile from time to time, at a purchase price of $1.60 per share.
On April 19, 2023, in connection with the Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Purchasers, requiring the Company to register the securities issued under the Purchase Agreement. Pursuant to the Registration Rights Agreement, the Company will be required to file, on or prior to May 19, 2023 (the “Filing Date”), a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) to register the resale of the Shares and the Warrant Shares.
The foregoing summaries of the Purchase Agreement, Pre-Funded Warrants, Breakeven Warrants and Registration Rights Agreement are not complete and are qualified in their entirety by reference to the full text of the form of the Purchase Agreement, Pre-Funded Warrants, Breakeven Warrants and Registration Rights Agreement attached hereto as Exhibits 10.1, 4.1, 4.2 and 10.2, respectively, to this Current Report on Form 8-K (the “Report”).
1
Item 3.02. Unregistered Sales of Equity Securities.
Recent AUGX News
- Augmedix to Participate in Upcoming Investor Conferences in May and June 2024 • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024 • GlobeNewswire Inc. • 04/30/2024 11:00:00 AM
- Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care • GlobeNewswire Inc. • 04/09/2024 11:00:00 AM
- Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide • GlobeNewswire Inc. • 04/04/2024 11:00:00 AM
- Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More • IH Market News • 03/19/2024 11:33:10 AM
- Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023 • GlobeNewswire Inc. • 03/18/2024 08:01:00 PM
- Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go • GlobeNewswire Inc. • 03/12/2024 11:00:00 AM
- Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:54:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:33:02 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:32:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:32:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:31:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:31:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 01:30:52 AM
- Augmedix to Participate in Citizens JMP Technology Conference • GlobeNewswire Inc. • 02/27/2024 12:00:00 PM
- Augmedix Names Tomer Levy as New Senior Vice President of Engineering • GlobeNewswire Inc. • 02/13/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/09/2024 07:14:12 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference • GlobeNewswire Inc. • 01/16/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 09:14:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:05:53 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM